Purpose:To analyze the phenotype of the corneal epithelium in patients with long-term follow-up who underwent autologous cultivated oral mucosal epithelial transplantation (COMET) using in vivo confocal microscopy (IVCM) and impression cytology with immunofluorescence staining (ICIF).Methods: Thirteen eyes from patients with severe limbal stem cell deficiency, who underwent COMET at least 48 months before, were recruited in this noncomparative cohort study. After eye examination, IVCM and ICIF were performed. Clinical manifestations of the cornea were evaluated and compared with epithelial findings detected by IVCM and ICIF [cytokeratin (CK) 3, CK7, and CK12]. Two corneal buttons derived from patients receiving the corneal transplantation post-COMET were sent for immunohistochemistry (CK3, CK6, CK7, CK12, paired box gene 6, p63, zonula occludens-1, and integrin b -1). Results:The mean age of patients was 51.2 6 20.6 years, and the mean follow-up time since COMET was 78.7 6 16.3 months. Six of 13 eyes showed clinically successful COMET. In these eyes, IVCM demonstrated predominant cornea-like epithelium and ICIF reported positivity for CK3 and CK12, confirming the presence of oral mucosal and corneal epithelium. Meanwhile, 7 eyes showed total conjunctiv-alization, corresponding with substantial conjunctival epithelium detected by IVCM and positivity for conjunctival (CK7) and oral mucosal epithelial (CK3) markers detected by ICIF. The immunohistochemistry of corneal buttons stained positive for oral mucosal, corneal epithelial, and stem cell markers (CK3, CK12, and p63). Conclusions:In long-term follow-up of COMET, epithelium of successful patients demonstrated cornea-like phenotype, whereas failed cases revealed mainly conjunctival phenotype. However, there were evidences that oral mucosal epithelial cells remained across the cornea in both successful and failed COMET as detected by IVCM and ICIF.

Objective: To investigate intravitreal aflibercept (IVA) injection as an adjunctive treatment to trabeculectomy with mitomycin C (TMC) and panretinal photocoagulation (PRP) for neovascular glaucoma (NVG).Materials and Methods: PRP and IVA (2 mg/0.05 ml) injection were given, and TMC was performed within 2weeks after IVA. Additional PRP, laser suture lysis, subconjunctival 5-fluorouracil injection, and bleb needlingwere performed after TMC if indicated. Best corrected visual acuity (BCVA), intraocular pressure (IOP), surgicalcomplications, and number of anti-glaucoma medications were collected.Results: Five eyes from 5 consecutive patients were included. Two eyes had proliferative diabetic retinopathy (PDR), 2 central retinal vein occlusion, and 1 ocular ischemic syndrome (OIS) (mean initial IOP: 46.8±6.8 mmHg). NVI regression occurred in one eye after PRP alone, and in one eye after PRP and IVA resulting in a good IOP control with topical medical therapy. The other 3 underwent TMC. The preoperative IOP was 34 (OIS), 54 (PDR), and 50 (PDR) mmHg. The 3-month postoperative IOP decreased to 8, 8, and 4 mmHg, respectively, and to 21, 10, and 6 mmHg, respectively, at the last visit. Only the one OIS eye required postoperative topical IOP-lowering medications. Final BCVA was improved, unchanged, and decreased in 2, 2, and 1 eye, respectively. No intraoperative/postoperative complications or NVI recurrence were observed (mean follow-up: 10.7 months).Conclusion: Intravitreal aflibercept was shown to be a potentially effective additional treatment to PRP and TMC in patients with NVG.

Objective: To assess the diagnostic ability of Cirrus high-definition optical coherence tomography (HD-OCT) parameters in patients with moderate or high myopia for detecting glaucoma, and to compare the thickness of the macular ganglion cell-inner plexiform layer (GC-IPL) in glaucomatous and normal eyes in both types of myopia.Materials and Methods: This prospective study enrolled moderately (spherical equivalent -3.00 to -6.00 diopters) and highly (spherical equivalent ≤ -6.00 diopters) myopic patients without (controls) and with (study) glaucoma. Cirrus HD-OCT was used to determine the thickness of the peripapillary retinal nerve fiber layer (RNFL) and the GC-IPL. The area under the receiver operating characteristic curve was analyzed to evaluate the glaucoma detection capability of each Cirrus HD-OCT parameter.Results: Seventy eyes (31 moderate myopia, 39 high myopia) were included. The parameters with the best diagnostic ability were minimum GC-IPL, inferior RNFL and average RNFL thickness in moderately myopic eyes, and average RNFL, inferior RNFL and inferotemporal GC-IPL thickness in highly myopic eyes. All parameters were thinner in glaucomatous than in normal eyes in both groups.Conclusion: Although macular GC-IPL thickness demonstrated high ability to detect glaucoma in patients with moderate or high myopia, it should be used in combination with other structural imaging and functional assessments for diagnosing glaucoma.